OpenURL Connection Search

Select item for more details and to access through your institution.

Retraction. Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between the NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations.
Published in:
2010
By:
- Cilloni, D;
- Messa, F;
- Rosso, V;
- Arruga, F;
- Defilippi, I;
- Carturan, S;
- Catalano, R;
- Pautasso, M;
- Panuzzo, C;
- Nicoli, P;
- Messa, E;
- Morotti, A;
- Iacobucci, I;
- Martinelli, G;
- Bracco, E;
- Saglio, G
Publication type:
corrected article
Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-κB in AML carrying NPM1 mutations.
Published in:
Leukemia (08876924), 2008, v. 22, n. 6, p. 1234, doi. 10.1038/leu.2008.68
By:
- Cilloni, D.;
- Messa, F.;
- Rosso, V.;
- Arruga, F.;
- Defilippi, I.;
- Carturan, S.;
- Catalano, R.;
- Pautasso, M.;
- Panuzzo, C.;
- Nicoli, P.;
- Messa, E.;
- Morotti, A.;
- Iacobucci, I.;
- Martinelli, G.;
- Bracco, E.;
- Saglio, G.
Publication type:
Article
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia.
Published in:
Leukemia (08876924), 2007, v. 21, n. 7, p. 1442, doi. 10.1038/sj.leu.2404670
By:
- Cilloni, D;
- Messa, F;
- Martinelli, G;
- Gottardi, E;
- Arruga, F;
- Defilippi, I;
- Carturan, S;
- Messa, E;
- Fava, M;
- Giugliano, E;
- Rosso, V;
- Catalano, R;
- Merante, S;
- Nicoli, P;
- Rondoni, M;
- Ottaviani, E;
- Soverini, S;
- Tiribelli, M;
- Pane, F;
- Baccarani, M
Publication type:
Article
CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536.
Published in:
2007
By:
- Morotti, A.;
- Parvis, G.;
- Cilloni, D.;
- Familiari, U.;
- Pautasso, M.;
- Bosa, M.;
- Messa, F.;
- Arruga, F.;
- Defilippi, I.;
- Catalano, R.;
- Rosso, V.;
- Carturan, S.;
- Bracco, E.;
- Guerrasio, A.;
- Saglio, G.
Publication type:
Letter
The NF-κB pathway blockade by the IKK inhibitor PS1145 can overcome Imatinib resistance.
Published in:
Leukemia (08876924), 2006, v. 20, n. 1, p. 61, doi. 10.1038/sj.leu.2403998
By:
- Cilloni, D.;
- Messa, F.;
- Arruga, F.;
- Defilippi, I.;
- Morotti, A.;
- Messa, E.;
- Carturan, S.;
- Giugliano, E.;
- Pautasso, M.;
- Bracco, E.;
- Rosso, V.;
- Sen, A.;
- Martinelli, G.;
- Baccarani, M.;
- Saglio, G.
Publication type:
Article

Found: 5

Retraction. Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between the NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations.

Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-κB in AML carrying NPM1 mutations.

WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia.

CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536.

The NF-κB pathway blockade by the IKK inhibitor PS1145 can overcome Imatinib resistance.